Cardioplegia Solution Recalled Nationwide for Sterility Assurance Concerns
Central Admixture Pharmacy Services recalls 613 bags of cardioplegia solution nationwide due to FDA inspection concerns about sterility assurance.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall where sterility assurance has been called into question by FDA inspection, representing a risk-of-harm to patients. However, no illnesses or injuries have been reported, and the hazard is theoretical rather than confirmed contamination.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling Cardioplegia Solution, Induction 4:1 Plasma-Lyte/Tromethamine, High Potassium. The product is a 500 mL sterile injectable solution distributed nationwide.
An FDA inspection called into question the sterility assurance of these products. Lack of adequate sterility assurance means the product may not meet pharmaceutical standards for sterility and safety.
The recall affects 613 bags with the following lot numbers and expiration dates: Lot 37-894299 (Exp 04/29/2023), Lot 37-897051 (Exp 05/11/2023), Lot 37-897368 (Exp 05/12/2023), Lot 37-898794 (Exp 05/18/2023), Lot 37-899614 (Exp 05/20/2023), and Lot 37-900608 (Exp 05/25/2023). The product was distributed nationwide.
Hospitals and healthcare facilities that received this product should check their inventory for affected lot numbers. Anyone with questions about this recall should contact the recalling firm or the FDA.
The recalled product
- Product
- Cardioplegia Solution, Induction 4:1 Plasma-Lyte/Tromethamine, High Potassium, packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0111-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Cardioplegia
- Hazard
- lack-of-sterility
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lot # 37-894299
- Exp 04/29/2023
- 37-897051
- Exp 05/11/2023
- 37-897368
- Exp 05/12/2023
- 37-898794
- Exp 05/18/2023
- 37-899614
- Exp 05/20/2023
- 37-900608
- Exp 05/25/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27